A Clinical Q&A on Shockwave Therapy: Applications and Evidence in Cochrane

An In-Depth Patient Guide to Shockwave Therapy in Cochrane

Extracorporeal Shock Wave Therapy (ESWT), commonly known as shockwave therapy, has become a prominent non-invasive treatment option within physiotherapy, sports medicine, and orthopedics. For residents of Cochrane and the surrounding Alberta foothills, understanding this technology is key to making informed decisions about musculoskeletal health. This guide adopts a question-and-answer format to explore the science, application, and clinical considerations of shockwave therapy from an objective, evidence-based perspective.

Disclaimer: The following information is for educational purposes only and does not constitute medical advice. The efficacy of any treatment can vary based on individual factors. Always consult with a qualified healthcare professional in Cochrane to determine if shockwave therapy is an appropriate option for your specific condition.

Q1: What exactly is Shockwave Therapy?

At its core, shockwave therapy is a modality that uses acoustic waves to carry high energy to painful spots and musculoskeletal tissues with subacute, subchronic, and chronic conditions. These are not electrical shocks. The device generates powerful but very short sound waves, which are then transmitted into the body via a handheld applicator. The goal is to initiate a pro-inflammatory response in the targeted tissue, effectively restarting a stalled healing process and stimulating the body's natural regenerative capabilities.

Q2: How does it differ from a therapeutic ultrasound?

This is a frequent and important point of clarification. While both use sound waves, their properties and therapeutic goals are vastly different. Therapeutic ultrasound uses high-frequency, low-energy sound waves to produce a thermal (heating) effect in deep tissues, which can help with blood flow and tissue relaxation. In contrast, shockwave therapy uses lower-frequency, high-energy acoustic pulses. These waves create a mechanical force, not a thermal one. This pressure disturbance is what triggers the cascade of biological responses associated with tissue repair and regeneration.

Q3: What conditions are commonly addressed with shockwave therapy?

Clinicians in Cochrane and globally utilize shockwave therapy for a range of tendinopathies and other musculoskeletal issues, particularly those that have become chronic. The evidence is strongest for conditions affecting the interface between tendon and bone (enthesopathies). Common applications include:

• Plantar Fasciitis: Chronic heel pain, often with or without a heel spur.
• Achilles Tendinopathy: Pain and dysfunction in the Achilles tendon.
• Patellar Tendinopathy (Jumper's Knee): Pain at the bottom of the kneecap.
• Lateral Epicondylitis (Tennis Elbow): Pain on the outside of the elbow.
• Medial Epicondylitis (Golfer's Elbow): Pain on the inside of the elbow.
• Calcific Tendinitis of the Shoulder: Shoulder pain caused by calcium deposits in the rotator cuff tendons.
• Greater Trochanteric Pain Syndrome (GTPS): Often referred to as hip bursitis.
• Hamstring Tendinopathy: Pain high in the hamstring near the ischial tuberosity.

Q4: What is the biological mechanism? How does it promote healing?

The mechanical stimulus from the shockwaves triggers a series of cellular and physiological events. This is not about simply 'breaking up' scar tissue, which is a common oversimplification. The process is more nuanced:

• Neovascularization: It stimulates the formation of new blood vessels, which improves blood supply and oxygenation to the treated tissue, a critical component of healing.
• Modulation of Inflammation: While it initially causes an acute inflammatory response, the long-term effect is the modulation of chronic inflammation. It helps transition the tissue from a stagnant, chronic inflammatory state to an active, acute healing phase.
• Stimulation of Collagen Production: The therapy encourages the production of new collagen, a vital protein for the repair of musculoskeletal tissues like tendons and ligaments.
• Pain Reduction: It can have a direct analgesic effect by over-stimulating nerve fibres, thereby blocking pain signals (based on the Gate Control Theory of Pain). It also helps deplete Substance P, a neurotransmitter associated with chronic pain.
• Dissolution of Calcifications: In conditions like calcific tendinitis, the mechanical energy can help break down calcium deposits, which are then cleared by the body's lymphatic system.

Think of it less as a direct 'fix' and more as a catalyst. Shockwave therapy acts as a biological wake-up call to tissues that are 'stuck' in a non-healing state, prompting them to resume the natural repair cycle.

Q5: What should a patient expect during a session in Cochrane?

A typical shockwave therapy session is relatively straightforward. First, the clinician will locate the area of pain through palpation. A water-based gel is applied to the skin over this area to ensure the shockwaves are transmitted efficiently. The therapist then places the applicator on the skin and begins the treatment. The device delivers a set number of pulses (usually 1,500 to 2,500 per session). The patient will feel a tapping or pulsing sensation, which can range from comfortable to moderately uncomfortable, especially over tender points. The intensity can be adjusted for patient tolerance. The treatment itself is short, typically lasting only 5 to 10 minutes.

Q6: Are there different types of shockwave machines?

Yes, and this is a key detail. The two main types are Focused Shockwave Therapy (FSWT) and Radial Shockwave Therapy (RSWT).

• Radial Shockwaves are pressure waves that are generated pneumatically (with compressed air). They diverge from the applicator, meaning their energy is highest at the surface and weakens as they penetrate deeper. This is the most common type found in physiotherapy clinics and is effective for more superficial conditions.
• Focused Shockwaves are generated electromagnetically or piezoelectrically and converge at a specific point deep within the body. This allows for precise targeting of deeper tissues. They are generally considered more powerful but are less common in standard clinical practice outside of specialized centres.

Most clinics in communities like Cochrane will utilize radial shockwave technology for the common tendinopathies listed above.

Q7: Who is not a suitable candidate for this treatment?

There are several contraindications. Shockwave therapy should not be performed over or near:

• Malignant tumours or cancerous tissue.
• Areas with active infection.
• The lungs, major blood vessels, or nerves.
• Open growth plates (in children or adolescents).
• The abdomen of a pregnant person.

Patients with blood clotting disorders or those taking anticoagulant medication also require careful consideration and may not be suitable candidates. A thorough assessment by a qualified practitioner is essential.

Q8: How many sessions are generally required?

A typical treatment protocol involves 3 to 5 sessions, spaced approximately one week apart. This allows the tissue time to respond to the stimulus between treatments. Some individuals may experience relief after the first or second session, but the full biological effect unfolds over several weeks to months as the tissue remodels. It is often used as part of a comprehensive rehabilitation plan that includes therapeutic exercise and activity modification, not as a standalone intervention.